Subsidiary concerns cloud valuations... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Subsidiary concerns cloud valuations...

Jun 2, 2001

A large part of the Indian fast moving consumer goods (FMCG) landscape is filled with companies vying for a plethora of product categories. Expanding product portfolios is an inherent strategy of the FMCG companies in India and all over the world. The aim has always been garner a great share of the consumer pie.

But in this entire milieu of brands, one company decided to take a different route. The company is Procter and Gamble Hygiene and Healthcare (PGHH), a 65 percent subsidiary of the US$ 38 billion FMCG major Procter & Gamble, USA. The Indian subsidiary despite being a focused two-product company has been successful in generating topline growth through price increases. It is the market leader in the anti-cold healthcare (Vicks) segment and feminine care (Whisper sanitary napkins). While the companys revenues grew at a compounded annual growth rate of 10 percent in the past 5 years, profits showed an encouraging growth rate of 25 percent. PGHH being the least cost producer of Vicks Vaporub among P&G facilities worldwide is also the sourcing base for all P&G subsidiaries in Asia.

The company realised early on that it could not match the distribution strengths which compatriot Hindustan Lever (HLL) possessed. Therefore the company truncated its distribution network and signed a distribution agreement with Marico for Clearasil, Old Spice, Camay range of soaps and Ariel detergent bar. To lend focus to its business, PGHH consciously decided to be present only in two products viz. Anti-cold (Vicks) and feminine care (Whisper). Thus it exited from the shampoo segment by selling Mediker (anti-lice shampoo) to Marico Industries for Rs 100 million (US$ 2 million) in 1999. PGHH also terminated its manufacturing agreement for shampoos with P&G Home Products, its parents' 100 percent subsidiary.

Margin advantage
OPM (%) NPM (%)
P&G 26.8 18.4
HLL 12.9 11.5
Colgate 7.5 4.9
Gillette 9.2 4.5
Reckitt 6.2 3.6
* OPM = Operating profit margin
* NPM = Net profit margin

However, the going is not all that smooth. PGHH's strategy has revolved around premium positioning of both its product categories. In a sense, the company has been focusing on margins (value) rather than volumes. But PGHHs topline growth in the last two years slowed down to a single digit due to stiff competition in the markets from low priced packs. The unorganised sector also gave a tough time to the company. Apart from the competition, the slowing market growth has also worried investors. The anti-cold healthcare segment registered a marginal 1.5 percent overall sales growth in 2000, with Vicks maintaining a 40 percent hold on this segment. But in sanitary napkins segment, Whisper continues to be the market leader with a 50 percent share despite the onslaught of cheaper products from competitors like Johnson and Johnson and HLL. Sales in this segment registered a 2 percent growth during fiscal year 2000.

Its strategy of focusing on premium segment of the market has however, led to a continuous improvement in its operating margins (26.8 percent in nine month period ended March 2001), which are among the highest in the FMCG industry.

Given PGHHs clear strategy on focusing on two products, as also its premium positioning, the company is better placed than most FMCG companies to clock double-digit growth figures both in its topline and bottomline in the medium term. In the long term however, PGHH's two-product focus might become a bane as competition picks up. To keep competition at bay, the company will have to keep increasing its ad spends, which in the long term may strain its profitability. In 1999, PGHHs advertisement expenditure as a percentage of turnover was 6.7 percent. In 2000, it increased to 9 percent. This has put pressure on the companys margins. There are also concerns regarding its parent's two 100 percent subsidiaries in India.

Due to the above reasons PGHH has been accorded lower valuations compared to its peers in the industry. Its market cap to sales ratio of 2.5 times is however, in line with other companies.

However, there is a silver lining for this company. PGHHs US based parent has identified India among the top three markets in the world in the healthcare segment. This will help PGHH get more research and an expanded product line in the healthcare segment from its parent and hopefully would also help de-risk its business.


Equitymaster requests your view! Post a comment on "Subsidiary concerns cloud valuations...". Click here!

  

More Views on News

P&G HYGIENE Announces Quarterly Results (3QFY20); Net Profit Up 9.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (up 9.5% YoY). Sales on the other hand came in at Rs 9 bn (up 5.0% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.

P&G HYGIENE Announces Quarterly Results (2QFY20); Net Profit Down 5.0% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (down 5.0% YoY). Sales on the other hand came in at Rs 9 bn (up 7.6% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.

P&G HYGIENE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 31, 2018 | Updated on Dec 31, 2018

Here's an analysis of the annual report of P&G HYGIENE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of P&G HYGIENE. Also includes updates on the valuation of P&G HYGIENE.

More Views on News

Most Popular

Multibaggers of the Next Decade (The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today (Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

P&G HYGIENE SHARE PRICE


Feb 28, 2020 (Close)

TRACK P&G HYGIENE

  • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

P&G HYGIENE - HYPERMARCAS COMPARISON

COMPARE P&G HYGIENE WITH

MARKET STATS